David Blaisdell, BA

A multistakeholder workgroup of oncology and quality measurement experts explored gaps in quality measures focused on oral oncolytic adherence and identified, prioritized, and refined measure concepts for further development.

A multistakeholder workgroup of...

06/16/2022

Journal of Clinical Pathways

Quality Outlook

The Oncology-Oral Health Value Bridge: Put Your Money Where Your Mouth Is

08/18/2022

Nina Regenold , MSc;

Kaitlyn Esselman , MHS;

Eva Lenoir , MPH;

David Blaisdell , BA;

Tom Valuck , MD, JD;

Nina Regenold, MSc, and colleagues highlight the need for payers and providers to include oral health in the development of value-based models in oncology care, arguing that doing so could lead to improved patient outcomes and lower costs of...

Nina Regenold, MSc, and...

08/18/2022

Journal of Clinical Pathways

Research Reports

Measuring Telehealth Quality in Cancer Care: We Don’t Know What We Don’t Know

11/15/2022

Tom Valuck , MD, JD;

David Blaisdell , BA;

The authors evaluate key quality considerations related to the use of telehealth in oncology in the context of the National Committee for Quality Assurance and the National Quality Forum's recommendations and discuss strategies to enhance...

The authors evaluate key quality...

11/15/2022

Journal of Clinical Pathways

Viewpoint

Catch Me If You Can: Aligning Quality Measurement With Oncology Innovation

12/17/2019

Tom Valuck , MD, JD;

Theresa Schmidt , MA, PMP, CSPO;

David Blaisdell , BA;

Breakthrough treatments in cancer care, including precision therapies tailored to specific patient factors, are driving rapid changes in the definitions of oncology quality and value. Efforts to implement value-based...

...

12/17/2019

Journal of Clinical Pathways

Quality Outlook

Quality Measures for Medicare’s Enhancing Oncology Model (EOM): New and Improved or More of the Same?

01/26/2023

David Blaisdell , BA;

Tom Valuck , MD, JD;

Sarena Ho , MSPH;

This blog discusses the Center for Medicare & Medicaid Service’s efforts to advance cancer quality through its new Enhancing Oncology Model (EOM) and presents recommendations for strengthening the EOM measure set and aligning measures across...

This blog discusses the Center...

01/26/2023

Journal of Clinical Pathways

From the Field

Care Coordination Between Prescribers and the Specialty Pharmacy for Multiple Myeloma: Qualitative Insights Into Designing a Quality Improvement Program for Multisite Community Oncology Practices

08/19/2020

Jeffrey F. Patton , MD;

David Blaisdell , BA;

Jonathan K. Kish , PhD, MPH;

Natalie Dickson , MD;

JaLyna Laney , RN, OCN;

Jesus G. Berdeja , MD;

Stacey W. McCullough , PharmD;

Annette Powers , PharmD, MBA;

Ronda Copher , PhD;

Tom Valuck , MD, JD;

Abstract: It is widely recognized that the quality of medical care received in the United States is suboptimal, and poor-quality care may contribute to disparities in cancer incidence and mortality. While...

...

08/19/2020

Journal of Clinical Pathways

Quality Outlook

Enhancing Value-Based Oncology Care: What Has CMMI Learned From the OCM?

09/22/2023

David Blaisdell , BA;

Tom Valuck , MD, JD;

We previously wrote about lessons from the Oncology Care Model (OCM) that the Center for Medicare and Medicaid Innovation (CMMI) could apply to the Enhancing Oncology Model (EOM). Subsequently, CMMI recently released an evaluation report for...

We previously wrote about...

09/22/2023

Journal of Clinical Pathways

Quality Outlook

Oncology Quality Measurement: Angst and Ambition

09/18/2019

Tom Valuck , MD, JD;

Manasi A. Tirodkar , PhD, MS;

David Blaisdell , BA;

In the first installment of the Quality Outlook commentary series, Tom Valuck, MD, JD, Discern Health, part of Real Chemistry, and colleagues assert the need for value-based solutions and adequate value assessment measurements to ensure that...

In the first installment of the...

09/18/2019

Journal of Clinical Pathways

Quality Outlook

Measuring Adherence to Oral Anticancer Medications: A Persistent Problem

06/06/2024

Tom Valuck , MD, JD;

David Blaisdell , BA;

This blog post discusses the importance of medication adherence and persistence in oncology, and how the Pharmacy Quality Alliance (PQA) is tackling the problem by exploring the construction of oral anticancer medication measures.

This blog post discusses the...

06/06/2024

Journal of Clinical Pathways